Exicure, Inc. (XCUR) stock
XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.90−0.08 (-8.15%)
Close on Nov 20, 2026Market cap $5.89MP/E –Yield –
Exicure net income
Net income is the profit left for shareholders after every expense, interest and tax.
Exicure's net income for the twelve months ending Sep 30, 2026 was -$5.21M. For fiscal 2025 it was -$4.95M. The highest annual figure on record is -$2.58M in fiscal 2022.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.95M | – |
| FY2024 | Dec 31, 2024 | -$9.70M | – |
| FY2023 | Dec 31, 2023 | -$16.91M | – |
| FY2022 | Dec 31, 2022 | -$2.58M | – |
| FY2021 | Dec 31, 2021 | -$64.10M | – |
| FY2020 | Dec 31, 2020 | -$24.67M | – |
| FY2019 | Dec 31, 2019 | -$26.30M | – |
| FY2018 | Dec 31, 2018 | -$22.41M | – |
| FY2017 | Dec 31, 2017 | -$11.01M | – |
| FY2016 | Dec 31, 2016 | -$16.94M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $642.00K | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.12M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.83M | -160.7% |
| Q4 FY2025 | Dec 31, 2025 | -$2.90M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.44M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.62M | – |
| Q1 FY2025 | Mar 31, 2025 | $3.01M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.18M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.09M | – |
| Q2 FY2024 | Jun 30, 2024 | -$600.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$829.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.49M | -108.1% |
| Q3 FY2023 | Sep 30, 2023 | -$5.26M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.76M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.41M | – |
| Q4 FY2022 | Dec 31, 2022 | $18.40M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.16M | – |
| Q2 FY2022 | Jun 30, 2022 | -$7.47M | – |
| Q1 FY2022 | Mar 31, 2022 | -$8.35M | – |
| Q4 FY2021 | Dec 31, 2021 | -$13.83M | – |
| Q3 FY2021 | Sep 30, 2021 | -$23.53M | – |
| Q2 FY2021 | Jun 30, 2021 | -$14.27M | – |
| Q1 FY2021 | Mar 31, 2021 | -$12.48M | -1185.0% |
| Q4 FY2020 | Dec 31, 2020 | -$12.69M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.82M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.31M | – |
| Q1 FY2020 | Mar 31, 2020 | $1.15M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.98M | – |
| Q3 FY2019 | Sep 30, 2019 | -$5.82M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.22M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.29M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.76M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.32M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.83M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.51M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.44M | – |
| Q2 FY2017 | Aug 31, 2017 | -$12.28K | – |
| Q4 FY2016 | Dec 31, 2016 | -$5.64M | – |
See a number that looks wrong?